Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer.

Yu H, Batenchuk C, Badzio A, Boyle TA, Czapiewski P, Chan DC, Lu X, Gao D, Ellison K, Kowalewski AA, Rivard CJ, Dziadziuszko R, Zhou C, Hussein M, Richards D, Wilks S, Monte M, Edenfield W, Goldschmidt J, Page R, Ulrich B, Waterhouse D, Close S, Jassem J, Kulig K, Hirsch FR.

J Thorac Oncol. 2017 Jan;12(1):110-120. doi: 10.1016/j.jtho.2016.09.002. Epub 2016 Sep 14.

2.

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.

Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, Shao H, Slingerland B, Torgov M, Williams SA, Foord O, Howard P, Jassem J, Badzio A, Czapiewski P, Harpole DH, Dowlati A, Massion PP, Travis WD, Pietanza MC, Poirier JT, Rudin CM, Stull RA, Dylla SJ.

Sci Transl Med. 2015 Aug 26;7(302):302ra136. doi: 10.1126/scitranslmed.aac9459.

3.

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients.

Winczura P, Sosińska-Mielcarek K, Duchnowska R, Badzio A, Lakomy J, Majewska H, Pęksa R, Pieczyńska B, Radecka B, Dębska-Szmich S, Adamowicz K, Biernat W, Jassem J.

Pathol Oncol Res. 2015 Sep;21(4):1229-36. doi: 10.1007/s12253-015-9957-0. Epub 2015 Jun 11.

4.

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.

Zhang L, Yu H, Badzio A, Boyle TA, Schildhaus HU, Lu X, Dziadziuszko R, Jassem J, Varella-Garcia M, Heasley LE, Kowalewski AA, Ellison K, Chen G, Zhou C, Hirsch FR.

J Thorac Oncol. 2015 Jul;10(7):1083-90. doi: 10.1097/JTO.0000000000000562.

5.

Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: the role of Rad51.

Sosińska-Mielcarek K, Duchnowska R, Winczura P, Badzio A, Majewska H, Lakomy J, Pęksa R, Pieczyńska B, Radecka B, Dębska S, Biernat W, Jassem J.

Breast. 2013 Dec;22(6):1178-83. doi: 10.1016/j.breast.2013.08.011. Epub 2013 Sep 20.

PMID:
24060578
6.

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators..

N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898.

7.

Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.

Badzio A, Wynes MW, Dziadziuszko R, Merrick DT, Pardo M, Rzyman W, Kowalczyk A, Singh S, Ranger-Moore J, Manriquez G, Gaire F, Jassem J, Hirsch FR.

J Thorac Oncol. 2010 Dec;5(12):1905-11. doi: 10.1097/JTO.0b013e3181f38f57.

8.

Pattern of care in locally advanced breast cancer: focus on local therapy.

Sinacki M, Badzio A, Wełnicka-Jaśkiewicz M, Bogaerts J, Piccart MJ, Therasse P, Smith IE, Hatschek T, Jassem J.

Breast. 2011 Apr;20(2):145-50. doi: 10.1016/j.breast.2010.08.008. Epub 2010 Sep 25.

PMID:
20870406
9.

Comparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast cancer.

Serkies K, Tarnawska Z, Blukis A, Badzio A, Jaskiewicz J, Jassem J.

J Contemp Brachytherapy. 2009 Mar;1(1):33-37. Epub 2009 Mar 23.

10.

Bcl-B expression in human epithelial and nonepithelial malignancies.

Krajewska M, Kitada S, Winter JN, Variakojis D, Lichtenstein A, Zhai D, Cuddy M, Huang X, Luciano F, Baker CH, Kim H, Shin E, Kennedy S, Olson AH, Badzio A, Jassem J, Meinhold-Heerlein I, Duffy MJ, Schimmer AD, Tsao M, Brown E, Sawyers A, Andreeff M, Mercola D, Krajewski S, Reed JC.

Clin Cancer Res. 2008 May 15;14(10):3011-21. doi: 10.1158/1078-0432.CCR-07-1955.

11.

Parallel-opposed fields versus four fields, and two- versus three-dimensional radiotherapy planning in thin patients with gynecological malignancies.

Bednaruk-Młynski E, Senkus-Konefka E, Szewczyk P, Badzio A, Jassem J.

Neoplasma. 2008;55(2):151-7.

PMID:
18237254
12.

Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer.

Ziemlewski A, Zienkiewicz J, Serkies K, Badzio A.

Strahlenther Onkol. 2007 Sep;183(9):512-6.

PMID:
17762926
13.

Gene copy numbers of HER family in breast cancer.

Zaczek A, Wełnicka-Jaśkiewicz M, Bielawski KP, Jaśkiewicz J, Badzio A, Olszewski W, Rhone P, Jassem J.

J Cancer Res Clin Oncol. 2008 Feb;134(2):271-9. Epub 2007 Jul 28.

PMID:
17661082
14.
15.

Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancer.

Senkus-Konefka E, Naczk E, Borowska I, Badzio A, Jassem J.

Radiother Oncol. 2006 Jun;79(3):304-9.

PMID:
16927464
16.

[The role of radiotherapy in the management of esophageal cancer].

Serkies K, Badzio A, Jassem J.

Pol Merkur Lekarski. 2005 Mar;18(105):332-5. Review. Polish.

PMID:
15997646
17.

Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.

Jereczek-Fossa BA, Badzio A, Jassem J.

Radiother Oncol. 2004 Aug;72(2):175-81.

PMID:
15297136
18.

A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.

Badzio A, Kurowski K, Karnicka-Mlodkowska H, Jassem J.

Eur J Cardiothorac Surg. 2004 Jul;26(1):183-8.

PMID:
15200999
19.

P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.

Jassem J, Jassem E, Jakóbkiewicz-Banecka J, Rzyman W, Badzio A, Dziadziuszko R, Kobierska-Gulida G, Szymanowska A, Skrzypski M, Zylicz M.

Cancer. 2004 May 1;100(9):1951-60.

20.

Supplemental Content

Loading ...
Support Center